National Fisheries Institute Statement on the Food and Drug Administration’s Draft Labeling Guidance

February 24, 2023 National Fisheries Institute

The Food and Drug Administration’s (FDA) newly issued draft guidance to help ensure appropriate labeling of plant-based beverages, marketed as milk alternatives, is a solid step in the right direction for regulators and consumers.  Highly processed, plant-based products masquerading as seafood for too long have contributed to consumer confusion and openly flouted existing regulations. Guidance for these products should mirror those now under consideration for “milk” products.

FDA Advises Restaurants, Retailers and Consumers to Avoid Raw Oysters from Baynes Sound, British Columbia, Canada Because They Are Potentially Contaminated with Norovirus

February 23, 2023 FDA

The FDA is advising consumers not to eat, and restaurants and food retailers not to sell, and to dispose of oysters that were harvested between January 16, 2023, and February 17, 2023, from Deep Bay, Baynes Sound subarea 14-8 or subarea 13-16 (landfile #140185) in British Columbia, Canada.

ABA Encouraged by the FDA’s Proposal to Redesign Human Foods Program

February 9, 2023 American Bakers Association

Statement from Eric Dell, President and CEO, American Bakers Association on the Proposed Redesign of Human Foods Program at the Food & Drug Administration.

Titans Global Inc Issues Allergy Alert on Undeclared Egg in “JSJ Chocolate Cake”, “JSJ Zsr Cake”, “JSJ DMC Leaf Cake”

February 8, 2023 FDA

Titans Global Inc. of City of Industry, CA, is recalling its 95g packages of “JSJ Chocolate Cake”, “JSJ ZSR Cake”, “JSJ DMC Leaf Cake” food treats because they may contain undeclared eggs. People who have allergies to eggs run the risk of serious or life-threatening allergic reaction if they consume these products.

ABA Recognizes Frank Yiannas’s Leadership at the FDA

February 3, 2023 American Bakers Association

Following the announcement of his upcoming departure from the agency, the American Bakers Association (ABA) recognizes and commends Frank Yiannas’s leadership and service to the Food and Drug Administration (FDA) during a time of tremendous global turmoil and technological change.